Dr. Golomb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
80 Central Park W
New York, NY 10023Phone+1 201-567-3680- Is this information wrong?
Education & Training
- NYU Grossman School of MedicineResidency, Surgery, 1950 - 1956
- Johns Hopkins University School of MedicineInternship, Transitional Year, 1949 - 1950
- University of Rochester School of Medicine and DentistryClass of 1949
Certifications & Licensure
- NY State Medical License 1950 - 2020
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 3 citationsA novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma.Fred T. Valentine, Frederick M. Golomb, Matthew N. Harris, Daniel F. Roses> ;Oncoimmunology. 2018 Jan 1
- 76 citationsGiant lipoma : case report and review of the literatureMiguel Sanchez, Frederick M. Golomb, Janet Moy, Jerome R. Potozkin> ;Journal of the American Academy of Dermatology. 1993 Feb 1
- 62 citationsVerification of a formula for determination of preexcision surgical margins from fixed-tissue melanoma specimens.Mark K. Silverman, Frederick M. Golomb, Alfred W. Kopf, Caron M. Grin-Jorgensen, Katrien Vossaert, Joyce P. Doyle, Marcia J. Levenstein> ;Journal of the American Academy of Dermatology. 1992 Aug 1
- Join now to see all
Grant Support
- Taxol/G-Csf + Standard Therapy Versus Standard Therapy For NSC Lung CancerNational Center For Research Resources1995–1996
- Decarbazine VS Decarbazine And Chemotherapy For Malignant MelanomaNational Center For Research Resources1994–1995
- Adjuvant Chemoradiation After Gastric Resection For AdenocarcinomaNational Center For Research Resources1994–1995
- Interferon And Chemotherapy For Metastatic Head/Neck CarconomaNational Center For Research Resources1994
- Interferon Alpha 2 For Resected High Risk Primary Metastatic MelanomaNational Center For Research Resources1994
- Adjuvant Chemotherapy And Endocrine Therapy For Node Negative Breast CancerNational Center For Research Resources1991–1994
- Tamoxifen Or CAF Treatment Of Postmenopausal Breast Cancer Patients-- Phase IIINational Center For Research Resources1993
- Chemo/Chemohormonal Therapy In Premenopausal WomenNational Center For Research Resources1992–1993
- Adjuvant Chemoendocrine Treatment For Postmenopausal WomenNational Center For Research Resources1992
- Recombinant Gamma Interferon For Malignant MelanomasNational Center For Research Resources1991
- Phase III Chemotherapy Of Advanced Soft Tissue SarcomasNational Center For Research Resources1991
- Cis-Platin/Etoposide And Bleomycin/Ifosfamide In Testicular CancerNational Center For Research Resources1991
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: